← All Topics / ade

FDA ADE reports for Ranitidine

ade_ranitidine_adverse_events

ade en 2026-07-22

Ranitidine — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Ranitidine is a active ingredient.

Total reports

Ranitidine: 58

Reports by species (top entries)

  • Dog 50
  • Human 6
  • Cat 1
  • Horse 1

Top reported reactions (VEDDRA terms, top entries)

  • Vomiting 13
  • Emesis 11
  • Lethargy (see also Central nervous system depression in 'Neurological') 8
  • Other abnormal test result NOS 8
  • Diarrhoea 6
  • Accidental exposure 5
  • Anorexia 4
  • Death 4
  • Decreased appetite 4
  • Elevated serum alkaline phosphatase (SAP) 4

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b24.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

FDA ADE reports for Ranitidine (active ingredient) — total reports, species & reaction breakdown
Source document: FDA FAERS / openFDA Animal & Veterinary Event Reports
US FDA Center for Veterinary Medicine (openFDA animal & veterinary event database)retrieved 2026-07-22

Verification file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b24.json

Link points to the issuing authority's site; a direct document link is still being verified.